NCT06108973

Evaluation of Consumption of Sevoflurane in Chronic Obstructive Pulmonary Disease Patients

Evaluation of Consumption of Sevoflurane in Chronic Obstructive Pulmonary Disease Patients Under General Anesthesia

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 45 (estimated)
• Sponsor: Employee's State Insurance Corporation, New Delhi · Other Government
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

All the Patients undergoing General Anesthesia and the patients who are having Chronic Obstructive Pulmonary Disease will be considered for this study. The Volume consumption of Sevoflurane will be studied in accordance with age, sex, duration , type of surgery, site of surgery and BMI.The volume consumption of sevoflurane is compared with Chronic Obstructive Pulmonary Disease and Normal Patients .

Detailed description

Chronic Obstructive pulmonary disease is known to escalate the consumption of Inhalation Agents in General Anesthesia. Hence the Data to Collect the Official Record

Conditions

• Chronic Obstructive Pulmonary Disease

Interventions

Type	Name	Description
DEVICE	Capnography	To know the Co2 graph in COPD and Normal patients under General Anesthesia

Timeline

• Start date: 2024-01-01
• Primary completion: 2024-12-30
• Completion: 2025-03-30
• First posted: 2023-10-31
• Last updated: 2023-10-31

Regulatory

• FDA-regulated device study